M. Da Costa

575 total citations
22 papers, 392 citations indexed

About

M. Da Costa is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, M. Da Costa has authored 22 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 8 papers in Surgery. Recurrent topics in M. Da Costa's work include Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (7 papers). M. Da Costa is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (7 papers). M. Da Costa collaborates with scholars based in Singapore, Ireland and Brazil. M. Da Costa's co-authors include H. P. Redmond, D. J. Bouchier‐Hayes, Judith H. Harmey, E. Kay, Graham P. Pidgeon, Seng Gee Lim, D.S. Sutedja, K. Prabhakaran, Chun‐Tao Wai and Aileen Wee and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and Transplantation.

In The Last Decade

M. Da Costa

21 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Da Costa Singapore 10 131 123 116 84 78 22 392
Zhifeng Xi China 14 140 1.1× 95 0.8× 157 1.4× 150 1.8× 72 0.9× 37 501
Zhenhua Tu China 9 209 1.6× 193 1.6× 144 1.2× 94 1.1× 18 0.2× 13 463
Cataldo Doria United States 14 143 1.1× 74 0.6× 184 1.6× 71 0.8× 27 0.3× 35 407
R Pellicci Italy 13 401 3.1× 268 2.2× 181 1.6× 105 1.3× 84 1.1× 40 727
Sunyi Ye China 11 81 0.6× 47 0.4× 113 1.0× 121 1.4× 29 0.4× 25 358
Toshiyuki Takeishi Japan 11 189 1.4× 111 0.9× 170 1.5× 80 1.0× 58 0.7× 26 368
Modan Yang China 9 86 0.7× 88 0.7× 76 0.7× 103 1.2× 35 0.4× 26 308
Weitao Que China 12 43 0.3× 35 0.3× 156 1.3× 80 1.0× 78 1.0× 27 342
Helen Zemack Sweden 10 85 0.6× 36 0.3× 112 1.0× 98 1.2× 12 0.2× 12 319
Naomi Funaki Japan 12 133 1.0× 114 0.9× 120 1.0× 91 1.1× 58 0.7× 25 389

Countries citing papers authored by M. Da Costa

Since Specialization
Citations

This map shows the geographic impact of M. Da Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Da Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Da Costa more than expected).

Fields of papers citing papers by M. Da Costa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Da Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Da Costa. The network helps show where M. Da Costa may publish in the future.

Co-authorship network of co-authors of M. Da Costa

This figure shows the co-authorship network connecting the top 25 collaborators of M. Da Costa. A scholar is included among the top collaborators of M. Da Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Da Costa. M. Da Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
François, J., et al.. (2021). Risk factors for keratoconus progression after treatment by accelerated cross-linking (A-CXL): A prospective 24-month study. Journal Français d Ophtalmologie. 44(6). 863–872. 8 indexed citations
3.
4.
Andrades, Michael Éverton, et al.. (2009). Serum-induced macrophage activation is related to the severity of septic shock. Inflammation Research. 58(2). 89–93. 4 indexed citations
5.
Wai, Chun‐Tao, et al.. (2006). MARS®: a futile tool in centres without active liver transplant support. Liver International. 27(1). 69–75. 24 indexed citations
6.
Lee, Guan Huei, Chee Leong Cheng, Aileen Wee, et al.. (2006). Prevalence and clinical associations of posttransplant fatty liver disease. Liver International. 27(1). 76–80. 63 indexed citations
7.
Sutedja, D.S., Chun Tao Wai, John Isaac, et al.. (2006). Long-term post-liver transplant complications of renal impairment and diabetes mellitus: data from Singapore.. PubMed. 47(7). 604–8. 2 indexed citations
8.
Costa, M. Da, K. Prabhakaran, M. Kaur, et al.. (2006). Impact of New Legislation on Presumed Consent on Organ Donation on Liver Transplant in Singapore: A Preliminary Analysis. Transplantation. 82(9). 1234–1237. 15 indexed citations
9.
Lee, Yew Mun, Chun Tao Wai, M. Da Costa, et al.. (2005). Bilirubin Appears to Be the Only Independent Variable Affecting Mortality on Liver Transplant Waiting List If Waiting Time Exceeds 1 Year. Transplantation Proceedings. 37(10). 4365–4366. 3 indexed citations
10.
Costa, M. Da, et al.. (2005). Tuberculosis Post-Liver Transplantation: A Rare but Complicated Disease. Annals of the Academy of Medicine Singapore. 34(2). 213–215. 8 indexed citations
11.
Fernandes, Maria da Luz, M. Da Costa, K.H. Lee, et al.. (2004). The MELD score may help to determine optimum time for liver transplantation. Transplantation Proceedings. 36(10). 3057–3059. 1 indexed citations
12.
Prabhakaran, K., Aileen Wee, D.S. Sutedja, et al.. (2004). Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant. Transplantation Proceedings. 36(8). 2313–2314. 13 indexed citations
13.
Novak, Estela Maria, Martin Metzger, Roger Chammas, et al.. (2003). Downregulation of TNF-α and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor. Gene Therapy. 10(23). 1992–1997. 24 indexed citations
14.
Toomey, Deirdre, et al.. (2002). Potentiation of the therapeutic index of interleukin-2 immunotherapy by combination with taurine in a syngeneic murine tumour model. Irish Journal of Medical Science (1971 -). 171(2). 85–88. 11 indexed citations
15.
16.
Lee, Kang H., M. Da Costa, Seng Gee Lim, & Kai-Chah Tan. (2002). Delayed tacrolimus is safe with basiliximab induction therapy. Liver Transplantation. 8(8). 732–732. 2 indexed citations
17.
Pidgeon, Graham P., Judith H. Harmey, E. Kay, et al.. (1999). The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. British Journal of Cancer. 81(8). 1311–1317. 125 indexed citations
18.
Redmond, H. P., et al.. (1996). 23 O - The anti-tumour efficacy of taurine and recombinant interleukin-2 in vivo. European Journal of Cancer. 32. S5–S5. 1 indexed citations
19.
Redmond, H. P., et al.. (1995). The anti-tumour efficacy of taurine and recombinant interleukin-2 in vivo. 30. 1 indexed citations
20.
Collier, Dean, R Y Calne, S Thiru, et al.. (1990). Rapamycin in experimental renal allografts in dogs and pigs.. PubMed. 22(4). 1674–5. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhifeng Xi Breakdown of academic impact, for papers by Zhenhua Tu Breakdown of academic impact, for papers by Cataldo Doria Breakdown of academic impact, for papers by R Pellicci Breakdown of academic impact, for papers by Sunyi Ye Breakdown of academic impact, for papers by Toshiyuki Takeishi Breakdown of academic impact, for papers by Modan Yang Breakdown of academic impact, for papers by Weitao Que Breakdown of academic impact, for papers by Helen Zemack Breakdown of academic impact, for papers by Naomi Funaki
Rankless by CCL
2026